Issuer and category are assigned by StocksXray rules from the fund name. Expense ratio and net assets come from SEC filings; where a fund does not file them (for example grantor trusts) the field stays empty.
Returns and risk
1 month
+0.8%
3 months
+3.1%
6 months
+10.7%
Year to date
+10.0%
1 year
+14.0%
3 years a year
n/a
5 years a year
n/a
10 years a year
n/a
Volatility (1 year)
6.9%
Largest drop, last year
−4.1%
Largest drop in our data
−4.1%
Total return includes distributions, from end-of-day prices adjusted for splits and distributions, to 6 Nov 2026. Periods of 3 years and longer are annualised and shown only when the fund's history is long enough. Volatility is the standard deviation of daily returns over the last year, annualised. Past performance does not guarantee future results.
Cost: expense ratio
1.94% a year
On $10,000 invested that is about $194 a year in fund costs, taken out of the fund's assets. The prospectus shows 2.27% before fee waivers.
Source: the fund's prospectus, as filed with the SEC on 24 Feb 2026 (risk/return summary data). Brokerage commissions and the bid-ask spread are separate costs.
The top 10 make up 101.2% of the fund, out of 394 holdings.
Positions as of 30 Jun 2026, from the fund's Form N-PORT filed with the SEC. Public N-PORT holdings are quarter-end positions published about 60 days later, so they can be months old and the fund may have changed since.
X-Ray look-through
StocksXray scores 26% of MKTN by weight (174 stocks in our S&P 500 coverage), so we can look inside the fund with our own numbers. The weighted average X-Ray Score of those stocks is 64 out of 100.
Undervalued 33%Fair 50%Overvalued 16%
Information Technology 35%Industrials 28%Health Care 27%Financials 13%Communication Services 7%Consumer Staples 6%
Weights are the SEC holdings weights dated 30 Jun 2026; scores and fair-value labels are today's. Labels follow our fair-value method ("Undervalued" means fair value is more than 17.5% above the price) and are model estimates, not forecasts or advice. How the X-Ray Score works.
MKTN: frequently asked questions
What is MKTN?
MKTN is the Federated Hermes MDT Market Neutral ETF, listed on NYSE ARCA. By our rules it is classed as "Equity". Its latest SEC filing lists 394 holdings.
What is the expense ratio of MKTN?
MKTN charges 1.94% a year after fee waivers (gross 2.27%), according to its prospectus filed with the SEC on 24 Feb 2026. On $10,000 that is about $194 a year in fund costs.
Does MKTN pay dividends?
Yes. MKTN paid 0.13 per share over the last 12 months, annual, a trailing yield of 0.46% on today's price. The latest ex-dividend date was 31 Dec 2025.
What does MKTN hold?
The largest holdings in the latest SEC filing are FEDERATED HERMES MONEY MARKET OBLIGATIONS TRUST (79.3%), VIKING HOLDINGS LTD (3.0%), GE VERNOVA INC (2.9%). The top 10 together make up 101.2% of the fund.
How has MKTN performed?
Total return including distributions to 6 Nov 2026: 1 year +14.0%. Past performance does not guarantee future results.
How does StocksXray rate the stocks inside MKTN?
We score 26% of the fund by weight (174 stocks) with our X-Ray Score: the weighted average is 64 out of 100. These are model estimates, not forecasts or advice.
Where the numbers come from
Prices and distributions end-of-day data from our market-data provider; returns are our own calculations from it.
Expense ratio and holdings SEC filings (prospectus risk/return data and Form N-PORT).
Category, issuer and leverage assigned by StocksXray rules from the fund name.
X-Ray look-through our scores applied to the SEC holdings.
StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.
